source
- Pfizer reports flat Q3 revenue as non-COVID sales rise 7% and acquired products grow 32%Pfizer posted third‑quarter revenue of $16.6 billion, essentially unchanged from $16.7 billion a year earlier. The flat top line reflects declines in its legacy Prevnar vaccine and COVID‑related pr…
- Merck KGaA sells its CDMO business and US sites to LonzaMerck KGaA announced it will divest its contract development and manufacturing organization (CDMO) operations, transferring ownership of five U.S. manufacturing facilities to Lonza. The transactio…